Search

everythinglearnresearchcommunity

for

Search:↓

Standard dosing is more effective for severe alopecia areata in children, but unorthodox dosing can be safe and considered if needed.

Baricitinib is more effective than tofacitinib for hair regrowth in alopecia patients.

Tofacitinib may effectively regrow hair in alopecia totalis patients.

A new therapy for a skin blistering condition has not been developed yet.

Oral JAK inhibitors effectively treat alopecia areata and are generally well-tolerated.

Baricitinib might help treat hair loss in lupus patients, but more research is needed.

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

Deuruxolitinib is FDA-approved for treating severe alopecia areata.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.

Baricitinib is a safe and effective alternative for alopecia areata patients who do not respond to tofacitinib.

Baricitinib works better than methotrexate for severe alopecia areata.

CI-1033 causes skin lesions in rats, similar to humans, due to EGF receptor inhibition.

Tofacitinib effectively treats severe alopecia areata, improving hair regrowth and patient satisfaction.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

CS12192 effectively treats alopecia areata with better safety than current options.

Ruxolitinib helps regrow hair in alopecia areata by blocking inflammation, reducing stress, and controlling cell death.

A man developed skin issues from cancer medication, which improved with specific treatments.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

Baricitinib is a relatively safe and effective treatment for severe alopecia areata.

Tofacitinib helped a man with alopecia totalis regrow all his hair.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

Baricitinib effectively treats both rheumatoid arthritis and alopecia areata.

Baricitinib successfully treated severe hair loss.

Ritlecitinib is an effective new treatment for Alopecia Areata.

Trametinib can effectively treat severe kaposiform lymphangiomatosis when other treatments fail.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

Ruxolitinib treatment may cause eyelash growth.